Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 139 | 1 | 157 | +19 |
| Shares | 20.5M | 60.9K | 19.1M | −1.38M (−6.7%) |
| Value | $694.0M | $2.06M | $909.0M | +$217.1M (+31.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (16)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 848,503 | $28.7M |
| Two Sigma Advisers, LP | 320,343 | $10.8M |
| Monashee Investment Management LLC | 100,000 | $3.38M |
| Engineers Gate Manager LP | 29,749 | $1.01M |
| Renaissance Technologies LLC | 29,500 | $998.0K |
| Qube Research & Technologies Ltd | 11,620 | $393.0K |
| Los Angeles Capital Management LLC | 8,357 | $283.0K |
| Twinbeech Capital LP | 8,125 | $275.0K |
| Group One Trading, L.P. | 7,754 | $262.0K |
| Vident Investment Advisory, LLC | 6,205 | $210.0K |
| FORA Capital, LLC | 906 | $31.0K |
| IFP Advisors, Inc | 591 | $19.0K |
| Wagner Wealth Management, LLC | 121 | $4.00K |
| Advisory Services Network, LLC | 100 | $3.00K |
| Evoke Wealth, LLC | 56 | $2.00K |
| Concord Wealth Partners | 3 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 60,930 | $2.06M |